FARP2
Basic information
Region (hg38): 2:241356285-241494841
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FARP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 12 | ||||
missense | 84 | 13 | 102 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 0 | |||||
Total | 0 | 0 | 84 | 23 | 7 |
Variants in FARP2
This is a list of pathogenic ClinVar variants found in the FARP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-241373128-A-C | Benign/Likely benign (Apr 01, 2022) | |||
2-241373156-C-T | not specified | Uncertain significance (Jun 30, 2023) | ||
2-241373159-T-G | not specified | Uncertain significance (Jun 11, 2021) | ||
2-241373178-T-C | Likely benign (Apr 24, 2018) | |||
2-241373187-G-A | not specified | Uncertain significance (May 09, 2023) | ||
2-241373202-G-A | Likely benign (Feb 09, 2018) | |||
2-241373240-C-T | Likely benign (Feb 01, 2023) | |||
2-241373241-A-G | Benign (Apr 23, 2018) | |||
2-241403831-A-G | not specified | Uncertain significance (May 14, 2024) | ||
2-241403882-G-A | not specified | Likely benign (Feb 02, 2022) | ||
2-241403895-A-G | not specified | Uncertain significance (Dec 08, 2023) | ||
2-241403921-C-G | Likely benign (Aug 15, 2018) | |||
2-241403930-T-A | not specified | Uncertain significance (Aug 02, 2021) | ||
2-241413302-C-G | Benign (Aug 08, 2018) | |||
2-241413332-G-A | Likely benign (Apr 19, 2018) | |||
2-241413340-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
2-241413360-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
2-241413369-C-G | not specified | Uncertain significance (May 09, 2024) | ||
2-241413370-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
2-241418067-G-T | not specified | Uncertain significance (Apr 15, 2024) | ||
2-241418095-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
2-241431695-A-G | not specified | Uncertain significance (Jan 12, 2024) | ||
2-241431701-T-C | Likely benign (Aug 15, 2018) | |||
2-241434192-G-A | not specified | Uncertain significance (Apr 28, 2022) | ||
2-241434195-G-C | not specified | Uncertain significance (Dec 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FARP2 | protein_coding | protein_coding | ENST00000264042 | 26 | 138599 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.64e-36 | 0.0000263 | 125462 | 0 | 286 | 125748 | 0.00114 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.331 | 639 | 616 | 1.04 | 0.0000372 | 6872 |
Missense in Polyphen | 250 | 246.42 | 1.0145 | 3009 | ||
Synonymous | -0.336 | 254 | 247 | 1.03 | 0.0000157 | 2057 |
Loss of Function | 0.377 | 56 | 59.1 | 0.947 | 0.00000304 | 665 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00227 | 0.00193 |
Ashkenazi Jewish | 0.000601 | 0.000595 |
East Asian | 0.00268 | 0.00267 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.00119 | 0.00117 |
Middle Eastern | 0.00268 | 0.00267 |
South Asian | 0.00111 | 0.00105 |
Other | 0.00131 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as guanine nucleotide exchange factor that activates RAC1. May have relatively low activity. Plays a role in the response to class 3 semaphorins and remodeling of the actin cytoskeleton. Plays a role in TNFSF11-mediated osteoclast differentiation, especially in podosome rearrangement and reorganization of the actin cytoskeleton. Regulates the activation of ITGB3, integrin signaling and cell adhesion (By similarity). {ECO:0000250}.;
- Pathway
- Adherens junction - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Developmental Biology;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Semaphorin interactions;Axon guidance;Regulation of CDC42 activity;Nectin adhesion pathway
(Consensus)
Recessive Scores
- pRec
- 0.192
Intolerance Scores
- loftool
- 0.735
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.31
Haploinsufficiency Scores
- pHI
- 0.0777
- hipred
- Y
- hipred_score
- 0.503
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.277
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Farp2
- Phenotype
- homeostasis/metabolism phenotype; skeleton phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- cell adhesion;neuron remodeling;Rac protein signal transduction;hair cycle process;osteoclast differentiation;actin cytoskeleton reorganization;regulation of integrin activation;regulation of Rho protein signal transduction;semaphorin-plexin signaling pathway;podosome assembly
- Cellular component
- cytoplasm;cytosol;cytoskeleton
- Molecular function
- Rho guanyl-nucleotide exchange factor activity;cytoskeletal protein binding;Rac guanyl-nucleotide exchange factor activity